Gilder Gagnon Howe & Co’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-7,028
| Closed | -$388K | – | 362 |
|
|
2020
Q3 | $388K | Sell |
7,028
-22
| -0.3% | -$1.22K | ﹤0.01% | 283 |
|
|
2020
Q2 | $445K | Buy |
7,050
+7,037
| +54,131% | +$444K | ﹤0.01% | 254 |
|
|
2020
Q1 | $1K | Sell |
13
-51,742
| -100% | -$3.98M | ﹤0.01% | 280 |
|
|
2019
Q4 | $4.11M | Buy |
+51,755
| New | +$4.11M | 0.04% | 178 |
|
|
2018
Q1 | – | Sell |
-8,854
| Closed | -$348K | – | 309 |
|
|
2017
Q4 | $348K | Sell |
8,854
-279
| -3% | -$11K | ﹤0.01% | 250 |
|
|
2017
Q3 | $284K | Sell |
9,133
-37
| -0.4% | -$1.15K | ﹤0.01% | 241 |
|
|
2017
Q2 | $251K | Sell |
9,170
-180
| -2% | -$4.93K | ﹤0.01% | 238 |
|
|
2017
Q1 | $345K | Buy |
+9,350
| New | +$345K | 0.01% | 223 |
|
|
2016
Q1 | – | Sell |
-297,053
| Closed | -$9.6M | – | 264 |
|
|
2015
Q4 | $9.6M | Buy |
+297,053
| New | +$9.6M | 0.15% | 96 |
|